# Campbell Clinic

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/campbell-clinic/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 67 |
| Citations | 100,670 |
| City | Memphis |
| Country | US |
| Description | Campbell Clinic is a research organisation in Memphis, US. OpenAlex records 1,919 works and 100,670 citations for it. 383 researchers list it as their most recent affiliation. |
| Homepage | http://www.campbellclinic.com/ |
| OpenAlex ID | https://openalex.org/I4210125649 |
| Region | Tennessee |
| Researchers | 383 |
| ROR ID | https://ror.org/02vbwbd19 |
| Type | healthcare |
| Works | 1,919 |

## University papers

- [Encorafenib, Binimetinib, and Cetuximab in <i>BRAF</i> V600E–Mutated Colorectal Cancer](https://scholariq.org/papers/encorafenib-binimetinib-and-cetuximab-in-i-braf-i-v600e-mutated-colorectal/)
- [Improved Survival in Metastatic Colorectal Cancer Is Associated With Adoption of Hepatic Resection and Improved Chemotherapy](https://scholariq.org/papers/improved-survival-in-metastatic-colorectal-cancer-is-associated-with-adoption-of/)
- [Duration of Adjuvant Chemotherapy for Stage III Colon Cancer](https://scholariq.org/papers/duration-of-adjuvant-chemotherapy-for-stage-iii-colon-cancer/)
- [Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, double-blind, multicentre, phase 3 study](https://scholariq.org/papers/ramucirumab-versus-placebo-in-combination-with-second-line-folfiri-in-patients/)
- [Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials](https://scholariq.org/papers/treatment-related-adverse-events-of-pd-1-and-pd-l1-inhibitors-in-clinical-trials/)
- [Chemotherapy-induced peripheral neuropathy: Prevention and treatment strategies](https://scholariq.org/papers/chemotherapy-induced-peripheral-neuropathy-prevention-and-treatment-strategies/)
- [Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: a JSMO–ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS](https://scholariq.org/papers/pan-asian-adapted-esmo-consensus-guidelines-for-the-management-of-patients-with/)
- [Treatment of Colorectal Peritoneal Carcinomatosis With Systemic Chemotherapy: A Pooled Analysis of North Central Cancer Treatment Group Phase III Trials N9741 and N9841](https://scholariq.org/papers/treatment-of-colorectal-peritoneal-carcinomatosis-with-systemic-chemotherapy-a/)
- [Factors Predicting Response, Perioperative Outcomes, and Survival Following Total Neoadjuvant Therapy for Borderline/Locally Advanced Pancreatic Cancer](https://scholariq.org/papers/factors-predicting-response-perioperative-outcomes-and-survival-following-total/)
- [Intravenous Calcium and Magnesium for Oxaliplatin-Induced Sensory Neurotoxicity in Adjuvant Colon Cancer: NCCTG N04C7](https://scholariq.org/papers/intravenous-calcium-and-magnesium-for-oxaliplatin-induced-sensory-neurotoxicity/)

## University top topics

Showing 8 of 25.

- [Shoulder Injury and Treatment](https://scholariq.org/topics/shoulder-injury-and-treatment/)
- [Total Knee Arthroplasty Outcomes](https://scholariq.org/topics/total-knee-arthroplasty-outcomes/)
- [Bone fractures and treatments](https://scholariq.org/topics/bone-fractures-and-treatments/)
- [Orthopaedic implants and arthroplasty](https://scholariq.org/topics/orthopaedic-implants-and-arthroplasty/)
- [Orthopedic Surgery and Rehabilitation](https://scholariq.org/topics/orthopedic-surgery-and-rehabilitation/)
- [Orthopedic Infections and Treatments](https://scholariq.org/topics/orthopedic-infections-and-treatments/)
- [Shoulder and Clavicle Injuries](https://scholariq.org/topics/shoulder-and-clavicle-injuries/)
- [Hip and Femur Fractures](https://scholariq.org/topics/hip-and-femur-fractures/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
